ORBIMED ADVISORS LLC
All 13F Filings
- Location
- New York, NY
- Most recent 13F
- Q4 2025
- Holdings value ($000)
- 4,899,392
- Description
- New York New York based relationship driven wealth allocation platform with a manager led operating structure and a valuation conscious and methodical investment mandate. The approach emphasizes fundamental research depth, active stewardship and governance oversight, and planning integrated mandate design for fiduciary household mandates. Portfolio governance emphasizes clear accountability, measured exposure, and resilient implementation through risk budget governance and mandate continuity.
- Website
- —
- Founded
- —
- Chairman
- —
- CEO
- —
- All SEC filings
- View on sec.gov
Sector allocation over time (stocks only)
Stacked by quarter. Hover to see detailed sector breakdown for any quarter.
| Quarter | Date Filed | Holdings | Value ($000) | Form Type | Name |
|---|---|---|---|---|---|
| Q4 2025 | 2/17/2026 | 108 | 4,899,392 | 13F-HR | ORBIMED ADVISORS LLC |
| Q3 2025 | 11/14/2025 | 109 | 4,255,380 | 13F-HR | ORBIMED ADVISORS LLC |
| Q2 2025 | 8/14/2025 | 102 | 4,004,111 | 13F-HR | ORBIMED ADVISORS LLC |
| Q1 2025 | 5/15/2025 | 110 | 4,194,646 | 13F-HR | ORBIMED ADVISORS LLC |
| Q4 2024 | 2/14/2025 | 118 | 4,861,410 | 13F-HR | ORBIMED ADVISORS LLC |
| Q3 2024 | 11/14/2024 | 118 | 5,503,519 | 13F-HR | ORBIMED ADVISORS LLC |
| Q2 2024 | 8/14/2024 | 114 | 5,064,526 | 13F-HR | ORBIMED ADVISORS LLC |
| Q1 2024 | 5/15/2024 | 114 | 5,459,960 | 13F-HR | ORBIMED ADVISORS LLC |
| Q4 2023 | 2/14/2024 | 110 | 5,007,244 | 13F-HR | ORBIMED ADVISORS LLC |
| Q3 2023 | 11/14/2023 | 127 | 4,707,565 | 13F-HR | ORBIMED ADVISORS LLC |
| Q2 2023 | 8/14/2023 | 126 | 5,518,910 | 13F-HR | ORBIMED ADVISORS LLC |
| Q1 2023 | 5/15/2023 | 124 | 5,094,046 | 13F-HR | ORBIMED ADVISORS LLC |
| Q4 2022 | 2/14/2023 | 115 | 5,227,458 | 13F-HR | ORBIMED ADVISORS LLC |
| Q3 2022 | 11/14/2022 | 131 | 5,387,000 | 13F-HR | ORBIMED ADVISORS LLC |
| Q2 2022 | 8/15/2022 | 144 | 5,518,815 | 13F-HR | ORBIMED ADVISORS LLC |
| Q1 2022 | 5/16/2022 | 144 | 6,167,262 | 13F-HR | ORBIMED ADVISORS LLC |
| Q4 2021 | 2/14/2022 | 158 | 7,778,455 | 13F-HR | ORBIMED ADVISORS LLC |
| Q3 2021 | 11/15/2021 | 172 | 9,099,330 | 13F-HR | ORBIMED ADVISORS LLC |
| Q2 2021 | 8/16/2021 | 159 | 9,886,767 | 13F-HR | ORBIMED ADVISORS LLC |
| Q1 2021 | 5/17/2021 | 158 | 10,694,926 | 13F-HR | ORBIMED ADVISORS LLC |
| Q4 2020 | 2/16/2021 | 149 | 11,428,040 | 13F-HR | ORBIMED ADVISORS LLC |
| Q3 2020 | 11/16/2020 | 143 | 7,956,183 | 13F-HR | ORBIMED ADVISORS LLC |
| Q2 2020 | 8/14/2020 | 135 | 7,102,993 | 13F-HR | ORBIMED ADVISORS LLC |
| Q1 2020 | 5/15/2020 | 142 | 5,950,362 | 13F-HR | ORBIMED ADVISORS LLC |
| Q4 2019 | 2/14/2020 | 136 | 7,004,336 | 13F-HR | ORBIMED ADVISORS LLC |
| Q1 2014 | 5/15/2014 | 140 | 8,131,588 | 13F-HR | ORBIMED ADVISORS LLC |
| Q4 2013 | 2/14/2014 | 120 | 6,804,448 | 13F-HR | ORBIMED ADVISORS LLC |
Swipe for more columns
Money flow by instrument (QoQ, ex-options)
Derivatives reported exposure ($000):
12.82 K
(0.3% of total reported value)
· QoQ Δ:
-72.8 K
| Type | Value ($000) | Share % | Inflow | Outflow | Net |
|---|---|---|---|---|---|
| Stocks | 4.865 M | 100.0% | 710.7 K | 0 | 710.7 K |
| Debt | 1.174 K | 0.0% | 0 | 1.51 K | -1.51 K |
Swipe for more columns
Fund Snapshot
Q4 2025
Latest filed
2/17/2026
Total value ($000)
4,899,392
Holdings
108
QoQ value change ($000)
644,012
(15.1%)
Value = total reported 13F value ($000), Holdings = number of positions.
13F Value over time
Holdings count over time
Sector allocation (latest, stocks only)
Methodology:
sector allocation is stocks-only;
instrument flow table is ex-options;
options exposure is shown separately.
Details.